129 related articles for article (PubMed ID: 9628325)
1. Interleukin pattern of Apert fibroblasts in vitro.
Bodo M; Carinci F; Baroni T; Becchetti E; Bellucci C; Giammarioli M; Pezzetti F; Tognon M; Carinci P
Eur J Cell Biol; 1998 Apr; 75(4):383-8. PubMed ID: 9628325
[TBL] [Abstract][Full Text] [Related]
2. Apert's syndrome: differential in vitro production of matrix macromolecules and its regulation by interleukins.
Bodo M; Carinci F; Baroni T; Giammarioli M; Bellucci C; Bosi G; Pezzetti F; Becchetti E; Evangelisti R; Carinci P
Eur J Clin Invest; 1997 Jan; 27(1):36-42. PubMed ID: 9041375
[TBL] [Abstract][Full Text] [Related]
3. Role of growth factors on extracellular matrix production by chick embryo fibroblasts in vitro. Antagonist effect of TGF-beta through the control of IL-1 and IL-1Ra secretion.
Bodo M; Carinci P; Baroni T; Bellucci C; Giammarioli M; Pezzetti F; Becchetti E
Cytokine; 1998 May; 10(5):353-60. PubMed ID: 9619373
[TBL] [Abstract][Full Text] [Related]
4. Detection and modulation of interleukin-1 receptor antagonist messenger ribonucleic acid and immunoreactivity in Graves' orbital fibroblasts.
Mühlberg T; Heberling HJ; Joba W; Schworm HD; Heufelder AE
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1018-28. PubMed ID: 9112998
[TBL] [Abstract][Full Text] [Related]
5. Intracellular IL-1 receptor antagonist is elevated in human dermal fibroblasts that overexpress intracellular precursor IL-1 alpha.
Higgins GC; Wu Y; Postlethwaite AE
J Immunol; 1999 Oct; 163(7):3969-75. PubMed ID: 10490999
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
7. Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis.
Shlopov BV; Gumanovskaya ML; Hasty KA
Arthritis Rheum; 2000 Jan; 43(1):195-205. PubMed ID: 10643716
[TBL] [Abstract][Full Text] [Related]
8. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1.
Yamamoto T; Eckes B; Krieg T
Biochem Biophys Res Commun; 2001 Feb; 281(1):200-5. PubMed ID: 11178980
[TBL] [Abstract][Full Text] [Related]
9. Differential in vitro phenotype pattern, transforming growth factor-beta(1) activity and mRNA expression of transforming growth factor-beta(1) in Apert osteoblasts.
Locci P; Baroni T; Pezzetti F; Lilli C; Marinucci L; Martinese D; Becchetti E; Calvitti M; Carinci F
Cell Tissue Res; 1999 Sep; 297(3):475-83. PubMed ID: 10460494
[TBL] [Abstract][Full Text] [Related]
10. Role of the extracellular matrix and growth factors in skull morphogenesis and in the pathogenesis of craniosynostosis.
Carinci P; Becchetti E; Bodo M
Int J Dev Biol; 2000; 44(6):715-23. PubMed ID: 11061436
[TBL] [Abstract][Full Text] [Related]
11. Expression of interleukin-1 beta and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits.
Lin SJ; Yen HT; Chen YH; Ku HH; Lin FY; Chen YL
J Cell Biochem; 2003 Mar; 88(4):836-47. PubMed ID: 12577317
[TBL] [Abstract][Full Text] [Related]
12. Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines.
Chen Z; Colon I; Ortiz N; Callister M; Dong G; Pegram MY; Arosarena O; Strome S; Nicholson JC; Van Waes C
Cancer Res; 1998 Aug; 58(16):3668-76. PubMed ID: 9721877
[TBL] [Abstract][Full Text] [Related]
13. Effects of hydroxyapatite particulate debris on the production of cytokines and proteases in human fibroblasts.
Ninomiya JT; Struve JA; Stelloh CT; Toth JM; Crosby KE
J Orthop Res; 2001 Jul; 19(4):621-8. PubMed ID: 11518271
[TBL] [Abstract][Full Text] [Related]
14. Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis.
Tam FW; Smith J; Cashman SJ; Wang Y; Thompson EM; Rees AJ
Am J Pathol; 1994 Jul; 145(1):126-36. PubMed ID: 8030744
[TBL] [Abstract][Full Text] [Related]
15. Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor.
Takemura H; Suzuki H; Fujisawa H; Yuhara T; Akama T; Yamane K; Kashiwagi H
J Rheumatol; 1998 Aug; 25(8):1534-9. PubMed ID: 9712097
[TBL] [Abstract][Full Text] [Related]
16. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression.
Pantschenko AG; Pushkar I; Anderson KH; Wang Y; Miller LJ; Kurtzman SH; Barrows G; Kreutzer DL
Int J Oncol; 2003 Aug; 23(2):269-84. PubMed ID: 12851675
[TBL] [Abstract][Full Text] [Related]
17. Production of IL-1 receptor antagonist by human in vitro-derived macrophages. Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor.
Janson RW; Hance KR; Arend WP
J Immunol; 1991 Dec; 147(12):4218-23. PubMed ID: 1836481
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between interleukin-6 and transforming growth factor-beta3 regulates extracellular matrix production by human fibroblasts from subjects with non-syndromic cleft lip and palate.
Baroni T; Carinci P; Bellucci C; Lilli C; Becchetti E; Carinci F; Stabellini G; Pezzetti F; Caramelli E; Tognon M; Bodo M
J Periodontol; 2003 Oct; 74(10):1447-53. PubMed ID: 14653390
[TBL] [Abstract][Full Text] [Related]
19. Effects of interleukins on Crouzon fibroblast phenotype in vitro. Release of cytokines and IL-6 mRNA expression.
Bodo M; Carinci F; Baroni T; Becchetti E; Giammarioli M; Bellucci C; Pezzetti F; Evangelisti R; Carinci P
Cytokine; 1996 Oct; 8(10):772-83. PubMed ID: 8980879
[TBL] [Abstract][Full Text] [Related]
20. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome.
Lomri A; Lemonnier J; Hott M; de Parseval N; Lajeunie E; Munnich A; Renier D; Marie PJ
J Clin Invest; 1998 Mar; 101(6):1310-7. PubMed ID: 9502772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
